FDAFDA · Food and drugs·Recall number D-396-2014
Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98
Published January 8, 2014 · Recall initiated: November 26, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: There is a potential for broken tablets.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide and Puerto Rico, American Samoa, Virgin Islands, and Canal Zone
- Lot
- Lot#: 32900349B, Exp: 12/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States